OIL 14.3% 16.0¢ optiscan imaging limited

Thank you "chand" for this lead, it made my day!Just for the...

  1. 747 Posts.
    lightbulb Created with Sketch. 13
    Thank you "chand" for this lead, it made my day!

    Just for the readers who do not have the time to search for the report and the page, the CARL ZEISS ANNUAL REPORT 2018 says on page 15:

    Neurosurgeons use ZEISS visualisation systems in around 10,000,000 surgeries performed around the world every year.

    Digital biopsy
    For decades, neurosurgical procedures have been performed using ZEISS visualization systems. These have always been developed in close collaboration with users, in order to meet the high demands of neurosurgery. With surgeon -controlled robotics, digital hybrid visualization and the micro-inspection tool QEVO, the Robotic Visualization System KINEVO 900 launched by ZEISS in 2018 brings new functionalities to microsurgery, which assist users during complex operations. A cutting-edge technology that offers neurosurgeons a higher level of safety in an almost seamless workflow, and greater surgical certainty.

    The ZEISS CONVIVO offers a visualization enhancement, which may be used for brain tumor resection. Neurosurgeons and pathologists will be able to perform a "digital biopsy". This digital biopsy tool makes it possible to visualize the tissue microstructure in real time, and allows an almost infinite number of samples to be examined directly in situ. The digital images captured are saved and are available for data analysis - anytime, anywhere. 







    Last edited by winkelmeier99: 13/02/19
 
watchlist Created with Sketch. Add OIL (ASX) to my watchlist
(20min delay)
Last
16.0¢
Change
0.020(14.3%)
Mkt cap ! $129.4M
Open High Low Value Volume
16.0¢ 16.5¢ 15.5¢ $6.478K 39.93K

Buyers (Bids)

No. Vol. Price($)
1 30000 15.5¢
 

Sellers (Offers)

Price($) Vol. No.
16.0¢ 17733 1
View Market Depth
Last trade - 15.18pm 25/11/2024 (20 minute delay) ?
OIL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.